{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:21Z","timestamp":1781459841184,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92269109"],"award-info":[{"award-number":["92269109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2208085Y29"],"award-info":[{"award-number":["2208085Y29"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.imbio.2025.153139","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:23:36Z","timestamp":1762482216000},"page":"153139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of NKG2A+ NK cell population in diagnosing severe COVID-19 patients"],"prefix":"10.1016","volume":"230","author":[{"given":"Chunqiu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2025.153139_bb0005","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to Lymphocyte Ratio: an Emerging Marker of the Relationships between the Immune System and Diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.imbio.2025.153139_bb0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-020-01590-2","article-title":"Drug repurposing against COVID-19: focus on anticancer agents","volume":"39","author":"Ciliberto","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2025.153139_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41571-019-0182-8","article-title":"The NKG2A immune checkpoint \u2014 a new direction in cancer immunotherapy","volume":"16","author":"Creelan","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.imbio.2025.153139_bb0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: a review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.imbio.2025.153139_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cac2.12394","article-title":"Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors","volume":"43","author":"Ghaedrahmati","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.imbio.2025.153139_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2361019","article-title":"SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expression","volume":"13","author":"Hasan","year":"2024","journal-title":"Emerging Microbes Infect."},{"key":"10.1016\/j.imbio.2025.153139_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2025.153139_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-med-042921-020956","article-title":"COVID-19: challenges of Viral Variants","volume":"74","author":"Jacobs","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.imbio.2025.153139_bb0045","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2025.153139_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1022890","article-title":"NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153139_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the Natural Killer Cell Inhibitory Receptor NKG2A increases activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imbio.2025.153139_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-020-02374-0","article-title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","volume":"18","author":"Liu","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imbio.2025.153139_bb0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2025.153139_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-024-00646-3","article-title":"Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.imbio.2025.153139_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007340","article-title":"Phase 1\/2 study of monalizumab plus durvalumab in patients with advanced solid tumors","volume":"12","author":"Patel","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.imbio.2025.153139_bb0080","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.imbio.2025.153139_bb0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"Schumacher","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2025.153139_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.11.024","article-title":"How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity","volume":"83","author":"Smorenberg","year":"2021","journal-title":"Eur. J. Intern."},{"key":"10.1016\/j.imbio.2025.153139_bb0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fphar.2020.01309","article-title":"Harnessing memory NK Cell to Protect against COVID-19","volume":"11","author":"Soleimanian","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.imbio.2025.153139_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/dyab012","article-title":"The role of C-reactive protein as a prognostic marker in COVID-19","volume":"50","author":"Stringer","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.imbio.2025.153139_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"Van Hall","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.imbio.2025.153139_bb0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2025.153139_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1258268","article-title":"Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia","volume":"14","author":"Zaderer","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153139_bb0120","article-title":"NKG2A is a NK cell exhaustion checkpoint for HCV persistence","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2025.153139_bb0125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.imbio.2025.153139_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis","volume":"96","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.imbio.2025.153139_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153139_bb0140","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41423-020-00551-1","article-title":"Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153139_bb0145","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:10:29Z","timestamp":1781457029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298525002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0171298525002736"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153139","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of NKG2A+ NK cell population in diagnosing severe COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153139"}}